Forbes -
27 Jan 2016 20:56
Leading medical device maker Abbott Laboratories is scheduled to report its Q4'15 earnings on January 28th. The company's revenues in 2015 have been largely affected by currency headwinds throughout the year. However, Abbott saw strong organic growth across all segments as well. For Q4'15, the company has guided to mid-single-digit growth in the sales from the diagnostics, nutritional, and medical optics segments. In contrast, it specifies flat growth in vascular sales and a low double-digit gro...
Share this Article
Comment on this Article
Please to comment